US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

35.79

-0.0047-0.01%

Volume:8K

Turnover:285.20K

Market Cap:97.34M

PE:- -

High:36.45

Open:35.93

Low:35.75

Close:35.79

52wk High:36.84

52wk Low:23.42

Shares:2.72M

Float Shares:2.72M

Volume Ratio:0.84

T/O Rate:0.29%

Dividend:0.26

Dividend Rate:0.72%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment

Political and General News Events from September 2

uniQure seeks accelerated approval for Huntington’s gene therapy

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)

Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets

Wall Street Analysts Are Bullish on Top Healthcare Picks

What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?

Simply Wall St.

Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts

FedEx Incheon Gateway Wins IATA CEIV Pharma Certification

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Investors Shrug Off Good News for Heart Patients from New Meds

Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says

MT Newswires Live

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01

Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition

MT Newswires Live

Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals

Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027

Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team

THOMSON REUTERS

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/IBBQ/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":35.7853,"timestamp":1788362655359,"preClose":35.79,"halted":0,"volume":7889,"delay":0,"changeRate":-0.00013132159821178273,"floatShares":2720001,"shares":2720001,"eps":0,"marketStatus":"Trading","change":-0.0047,"latestTime":"09-02 11:29:54 EDT","open":35.93,"high":36.45,"low":35.7472,"amount":285197.353252,"amplitude":0.019637,"askPrice":35.88,"askSize":3300,"bidPrice":35.82,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":35.79,"sharesOutstanding":2520001,"nav":35.43802,"aum":96391449.83802,"dividendRate":0.007154,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":35.79,"preClose":35.79,"latestTime":"07:00 EDT","volume":100,"amount":3579.2799999999997,"timestamp":1788346812804,"change":0,"changeRate":0,"amplitude":0.007823},"postHourTrading":{"tag":"盘后","latestPrice":35.79,"preClose":35.79,"latestTime":"19:30 EDT","volume":10,"amount":357.9,"timestamp":1788305405837,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.838882,"impliedVol":0.2723,"impliedVolPercentile":0.8929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":2720001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.838882,"shares":2720001,"dividePrice":0.256,"high":36.45,"amplitude":0.019637,"preClose":35.79,"low":35.7472,"week52Low":23.42,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":35.7853,"committee":-0.885714,"eps":0,"divideRate":0.007154,"volume":7889,"delay":0,"ttmEps":0,"open":35.93,"prevYearClose":28.3962,"prevWeekClose":35.47,"prevMonthClose":35.4742,"prevQuarterClose":32.66,"fiveDayClose":36.57,"twentyDayClose":32.93,"sixtyDayClose":28.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"IBBQ","amount":0.0287,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1126045427","title":"OCUMENSION-B Completes Patient Enrollment in Phase III Trial of Dry Eye Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1126045427","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126045427?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:16","pubTimestamp":1788351373,"startTime":"0","endTime":"0","summary":"OCUMENSION-B (01477) has announced the completion of patient enrollment for its Phase III clinical trial of OT-211 (TRYPTYR® acotiamide eye drops) in the People's Republic of China, with a total of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","MDTX","PSYK","01477","IBBJ","BK1574","BK1191","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664197218","title":"Political and General News Events from September 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664197218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664197218?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:08","pubTimestamp":1788350892,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 2Sept 2 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U10K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE0009355771.USD","LU1057294990.SGD","BK4533","SG9999001440.SGD","BK4566","LU0122379950.USD","LU0058720904.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","PJP","LU0289739699.SGD","PBE","LU0320765992.SGD","LU1571399168.USD","BK4139","BK4588","IE00BJJMRZ35.SGD","IBBQ","IE00B2B36J28.USD","LU2242652126.USD","LU0109394709.USD","LU1023059063.AUD","IE0002141913.USD","BK4581","BK4534","LU2112291526.USD","BK4585","LU0889565916.HKD","LU1061106388.HKD","IBB","TBXU","AMGN","BBH","IE00B4R5TH58.HKD","LU2242646821.SGD","LU1983299246.USD","LU0868494617.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819175","title":"uniQure seeks accelerated approval for Huntington’s gene therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819175?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:59","pubTimestamp":1788350375,"startTime":"0","endTime":"0","summary":"The latest update is out from uniQure ( ($QURE) ). On September 2, 2026, uniQure submitted a Biologics License Application to the U.S. Food and Dru...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/uniqure-seeks-accelerated-approval-for-huntingtons-gene-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LFSC","IBBQ","SYNB","FBT","TBXU","IBB","GNOM","BK4585","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","LU0889565916.HKD","BK4568","IE0002270589.USD","TMED","LU0289739699.SGD","BK4566","MEDI","LU0859254822.USD","SG9999015986.USD","BK4532","IBB","IE00B3T34201.USD","SG9999015978.USD","LU1674673691.USD","IE00B7SZLL34.SGD","BIB","LU1023059063.AUD","LU1934455863.HKD","BK4585","IE00B19Z3581.USD","LU0882574055.USD","LU1066053197.SGD","LU2324357040.USD","LU1778281490.HKD","LU0122379950.USD","LU0058720904.USD","LU1934455194.USD","BMED","BK4588","BK4578","LU0823416689.USD","LU1674673428.USD","BBH","LU1585245621.USD","LU1061106388.HKD","LU2087621335.USD","SG9999015952.SGD","IBBQ","LU1037948541.HKD","LU2089984988.USD","LU1066051498.USD","GILD","IE00BZ1G4Q59.USD","LU2112291526.USD","LU0109394709.USD","TBXU","LU0965509101.SGD","LU0114720955.EUR","LU0965509283.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664081594","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664081594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664081594?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:50","pubTimestamp":1788346221,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Alumis Inc. (ALMS) an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alumis-inc-alms-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALMS","LU1778281490.HKD","BK4581","LU2023251221.USD","IE0002141913.USD","LU1116320901.HKD","LU2417539215.USD","LU0265550359.USD","LU2089283258.USD","LU0162691827.USD","LU1061106388.HKD","LU0496365809.HKD","PBE","XBI","VRTX","IE0009355771.USD","LU0265550946.USD","IBBQ","LU1093756325.SGD","GNMX","HCSG","IE00B3T34201.USD","LU0158827948.USD","LU1674673691.USD","MDT","IE00B19Z3B42.SGD","BK4533","LU0234570918.USD","XLV","LABU","LU0058720904.USD","IDNA","LU0314106906.USD","LU1057294990.SGD","LU2456880835.USD","LU2112291526.USD","IE00B2B36J28.USD","BIB","VERX","IBB","SG9999001176.SGD","TBXU","LU1506573853.SGD","LU1291159041.SGD","BBH","IE00B894F039.SGD","LU0106261372.USD","BK4588","BK4139","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179166528","title":"Guangdong Zhongsheng Pharmaceutical (002317.SZ) Secures NMPA Acceptance for Expanded Indication Trial of Onradivir Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1179166528","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179166528?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343503,"startTime":"0","endTime":"0","summary":"Guangdong Zhongsheng Pharmaceutical Co.,Ltd. (002317.SZ) has announced that its controlling subsidiary, Guangdong Zhongsheng Ruichuang Biotech Co., Ltd., recently received formal acceptance from...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BMED","MDTX","IBBJ","BK0077","002317","BK0188","BK0239","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664589238","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2664589238","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664589238?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:40","pubTimestamp":1788334818,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Cabaletta Bio (CAB...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-322?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU1093756325.SGD","LU2362540622.SGD","TBXU","LABU","BK4581","IE00B2B36J28.USD","BIB","IBBQ","IDNA","LU0289739699.SGD","BK4533","VRTX","XBI","LU0823416689.USD","SG9999013999.USD","BBH","IE00B19Z9P08.USD","BK4588","LU0566484027.USD","LU2417539215.USD","LU0029874061.USD","HCSG","IE00B19Z3581.USD","BK4137","IE00BJJMRZ35.SGD","LU0061475181.USD","LU0432979614.USD","LU0079474960.USD","LU0320765992.SGD","LU1035775433.USD","LU0889565916.HKD","LU0109394709.USD","LU0234570918.USD","LU0757428866.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU1674673691.USD","GNMX","PBE","LU2324357040.USD","BK4567","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","VERX","XLV","SG9999001176.USD","LU2456880835.USD","LU1674673428.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664689541","title":"What Does Crinetics Pharmaceuticals (CRNX) Delisting Mean After The Takeover Closed?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664689541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664689541?lang=en_us&edition=fundamental","pubTime":"2026-09-02 10:23","pubTimestamp":1788315823,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals completed its acquisition of Crinetics Pharmaceuticals (NasdaqGS:CRNX), resulting in Crinetics becoming a wholly owned subsidiary.\nCrinetics has been delisted from the Nasdaq, with leadership changes announced as part of its integration into Vertex's operations.\nThe transaction ends Crinetics' status as an independent public company and shifts its future direction under Vertex's control.\n\nFor readers tracking consolidation in biopharma and looking for more stock ideas...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crnx/crinetics-pharmaceuticals/news/what-does-crinetics-pharmaceuticals-crnx-delisting-mean-afte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999001176.SGD","BK4139","LU1093756168.USD","BIB","CRNX","IE00BJT1NW94.SGD","IBBQ","BK4023","IE0002141913.USD","LU1585245621.USD","LU0061475181.USD","BK4585","LU0432979614.USD","LU2456880835.USD","LU0417517546.SGD","IE00B4R5TH58.HKD","IBB","SGXZ57979304.SGD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","PBE","BK4588","LU0234570918.USD","LU1035775433.USD","LU2362540622.SGD","LU2417539215.USD","BBH","IE00BJJMRZ35.SGD","BK4567","IE00B19Z9Z06.USD","BK4533","GNMX","LU2462157665.USD","IE0009355771.USD","VRTX","IE00B2B36J28.USD","BK4007","LU1093756325.SGD","TBXU","IDNA","LU0058720904.USD","LU0320765992.SGD","LU1674673428.USD","LU1815336091.USD","LU0256863811.USD","VERX","LU1430594728.SGD","IE0002270589.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185564913","title":"Betta Pharma's Hong Kong IPO: A Profit Pioneer Faces Patent Cliffs and Pipeline Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=1185564913","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185564913?lang=en_us&edition=fundamental","pubTime":"2026-09-02 09:20","pubTimestamp":1788312055,"startTime":"0","endTime":"0","summary":"After a five-year hiatus, Betta Pharmaceuticals Co., Ltd. is once again knocking on the doors of the Hong Kong stock exchange, carrying the mantle of being the \"first domestic innovative targeted...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","FRHC","LNGR","300558","BK1161","REDS","BK4127","KCE","06978","159992","MEDX","BK1574","IBBQ","IPOS","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664743862","title":"FedEx Incheon Gateway Wins IATA CEIV Pharma Certification","url":"https://stock-news.laohu8.com/highlight/detail?id=2664743862","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664743862?lang=en_us&edition=fundamental","pubTime":"2026-09-02 08:30","pubTimestamp":1788309037,"startTime":"0","endTime":"0","summary":"FedEx Incheon Gateway wins IATA CEIV Pharma certificationFedEx’s Incheon Gateway at Incheon International Airport secured IATA CEIV Pharma certification for temperature-controlled pharmaceutical air c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7spGmF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU2417539215.USD","BK4533","IBBQ","HULL","IE0002141913.USD","LU0234570918.USD","LU1585245621.USD","LU2089984988.USD","SGXZ57979304.SGD","TBXU","SG9999013999.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","VRTX","LU2456880835.USD","BK4139","SG9999001176.SGD","LU0823416689.USD","LU1035775433.USD","LU1778281490.HKD","BBH","LU0251142724.SGD","LU0061475181.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU0310800965.SGD","GNMX","LU0072461881.USD","IE00B19Z9Z06.USD","IE0002270589.USD","LU1267930227.SGD","LU1430594728.SGD","LU1069344957.HKD","IBB","LU0109394709.USD","BIB","LU1571399168.USD","PBE","LU2236285917.USD","LU2237438978.USD","SHPP","LU0006061336.USD","IDNA","IE00B19Z3B42.SGD","BK4585","LU0058720904.USD","FDX","LU1674673691.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999869","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:35","pubTimestamp":1788294900,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 2.45% to $149.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.69% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Pfizer Inc.  rose 0.32% to $28.55, and Abbott Laboratories  fell 1.30% to $108.93.Trading volume  remained 2.1 million below its 50-day average volume of 6.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","GILD","BK4532","LU0859254822.USD","BK4550","LU0320765992.SGD","BK4578","LU0965509283.SGD","LU1061106388.HKD","LU1674673691.USD","LU1023059063.AUD","LU1839511570.USD","BIB","LU0234570918.USD","LU0861579265.USD","LU1934455194.USD","TBXU","LU1430594728.SGD","TMED","LU1778281490.HKD","LU1057294990.SGD","LU1674673428.USD","BK4139","LU0882574055.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1066051498.USD","LU1037948897.HKD","LU0965509101.SGD","LU0965508806.USD","LU2087621335.USD","IBBQ","IE00B7SZLL34.SGD","SG9999015952.SGD","LU0965509010.AUD","LU1585245621.USD","BK4566","MEDI","LU2112291526.USD","IE00B3T34201.USD","LU0889565916.HKD","BBH","LU2357627491.SGD","LU2324357040.USD","LU2468319806.SGD","LU0114720955.EUR","IE00B19Z3581.USD","LU1571399168.USD","SG9999015986.USD","LU0289739699.SGD","IE00BSNM7G36.USD","IBB","BK4588","BK4583","LU0058720904.USD","BMED","LU0109394709.USD","BK4585","LU1037948541.HKD","LU1934455277.USD","LU0122379950.USD","LU1934455863.HKD","SG9999015945.SGD","SG9999015978.USD","LU2089984988.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4568","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","WDNA","BK4139","IE00B19Z3B42.SGD","BMED","TBXU","LU1066053197.SGD","MRNX","BK4551","IE00B7SZLL34.SGD","LU2324357040.USD","LU0965508806.USD","LGHT","LU0965509010.AUD","BIB","GILD","LU1934455277.USD","LU0320765992.SGD","SG9999015945.SGD","LU2112291526.USD","IE00BZ1G4Q59.USD","BK4583","BK4566","LU0289739699.SGD","LU1430594728.SGD","LU0109394709.USD","LU0823416689.USD","LU0861579265.USD","BK4588","LU1037948541.HKD","LU1571399168.USD","TMED","BK4533","LU0058720904.USD","LU1934455194.USD","LU1057294990.SGD","IBB","LU1934455863.HKD","IBBQ","GNOM","IDNA","LU2089984988.USD","LU0234570918.USD","BK4568","LU2468319806.SGD","BBH","MEDI","BK4534","BK4501","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866385","title":"Investors Shrug Off Good News for Heart Patients from New Meds","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866385","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866385?lang=en_us&edition=fundamental","pubTime":"2026-09-02 03:27","pubTimestamp":1788290820,"startTime":"0","endTime":"0","summary":"This year's run in drug stocks gained vigor from new treatments for heart attacks and strokes. Maybe some of those stocks are losing wind.At this past weekend's congress of the European Society of Car","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU1983299246.USD","IBB","IE00BJT1NW94.SGD","LU2112291526.USD","IE0002141913.USD","BK4585","LU1861559042.SGD","LU2242646821.SGD","LU2089984988.USD","BBH","BK4534","LU0320765992.SGD","LU2468319806.SGD","BK4211","LU1061106388.HKD","IE00B4R5TH58.HKD","CRSP","LU1057294990.SGD","BK4566","ISBC","IE0009355771.USD","BK4588","LU0289739699.SGD","IE00BJJMRZ35.SGD","TBXU","PBE","BK4556","BK4611","PJP","SG9999001440.SGD","LU0058720904.USD","BIB","AMGN","BK4599","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0889565916.HKD","BK4139","LU0868494617.USD","IE00B2B36J28.USD","LU0122379950.USD","BK4533","BK4581","LU0109394709.USD","LU1861558580.USD","ARKG","IBBQ","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664850925","title":"Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2664850925","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664850925?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:29","pubTimestamp":1788276594,"startTime":"0","endTime":"0","summary":"Regeneron Pharmaceuticals  may broaden its long-running drug partnership with Sanofi  to include several new immunology medicines, though any financial benefits would likely take time to show up, RBC Capital Markets said Tuesday in a report.Only Dupixent and Kevzara are currently covered under the collaboration, and both companies have said they're open to renegotiating the agreement, RBC said.The companies could fold additional pipeline drugs into the partnership and potentially update the financial terms, the report said. Regeneron could seek a more even profit split globally, compared with the current structure in which Sanofi funds most development costs upfront and Regeneron reimburses those expenses over time, RBC said.RBC maintained its sector-perform rating on Regeneron stock and its $737 price target.Regeneron shares rose 1.9% in Tuesday trading, and Sanofi gained 0.5%.Price: 814.29, Change: +15.21, Percent Change: +1.90","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1917777945.USD","IBB","LU0823434583.USD","TBXU","LU0289739699.SGD","LU2362541273.HKD","LU2237438978.USD","LU2362541513.USD","LU0320765992.SGD","IE00BFXG1179.USD","LU0882574055.USD","REGN","BK4588","IBBQ","SNYNF","LU0823416689.USD","LU2089984988.USD","LU0889565916.HKD","LU0114720955.EUR","BK4139","LU2023250504.SGD","BK4007","LU0109394709.USD","LU2106854487.HKD","BBH","SNY","LU0823434740.USD","LU0058720904.USD","LU0053666078.USD","BK4585","LU2468319806.SGD","LU1974910355.USD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585774","title":"NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-09-01","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664585774?lang=en_us&edition=fundamental","pubTime":"2026-09-01 23:01","pubTimestamp":1788274879,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EDT on 2026-09-01Nasdaq 100.NDXTop PerformersPercent ChangeApple Inc.AAPL.OQ+2.3%Constellation Energy CorpCEG.OQ+2.2%Regeneron Pharmaceuticals, Inc.REGN.OQ+1.9%Workday, Inc.WDAY.OQ+1.8%Walmart IncWMT.OQ+1.5%Bottom PerformersPercent ChangeAxon Enterprise, Inc.AXON.OQ-7.1%CrowdStrike Holdings, Inc.CRWD.OQ-7.1%Astera Labs, Inc.ALAB.OQ-5.6%Palo Alto Networks, Inc.PANW.OQ-5.5%Cadence Design Systems, Inc.CDNS.OQ-5.2%The Nasdaq 100.NDXlost 267.60 points, or 0.91%, to 29,189.37 and recorded no new highs and no new lows. 26 stocks rose and 75 fell as declining issues outnumbered advancers by about a 2.9-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL8N44T1ID:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","HK0000914686.HKD","LU0823416689.USD","BK4504","IE000Q6AESB8.SGD","LU2637965513.SGD","LU0456855351.SGD","LU1206712785.SGD","IE0009G5SDU7.USD","IE00B19Z8X17.USD","HK0000532082.HKD","IBBQ","UGE","LU2430703178.SGD","LU0274383776.USD","SGXZ80539844.SGD","LU2592432038.USD","LU1778281490.HKD","LU0109391861.USD","LU0672654240.SGD","CEG","IE0004091025.USD","SG9999014575.USD","PALD","LU0265550946.USD","LU0157215616.USD","LU1814569148.SGD","LU2065171402.SGD","IE00B894F039.SGD","LU2543165471.USD","LU0314106906.USD","LU0353189680.USD","BK4533","LU1791710400.SGD","AAPX","CLOD","LU1623119135.USD","LU2237443549.SGD","NLR","IE00B7KXQ091.USD","LU2054465674.USD","WMTI","LU2602419157.SGD","LU0308772762.SGD","LU0096364046.USD","LU2552382215.SGD","LU2210150020.SGD","HK0000306685.HKD","IE00B7SZLL34.SGD","LU1280957306.USD","LU0719512351.SGD","IE000BZT7R73.USD","AAPB","IDU","IVEP","SG9999015952.SGD","LU1127390331.HKD","CRWD","IE000M9KFDE8.USD","LU2023251221.USD","SG9999015358.SGD","LU0124384867.USD","URAN","LU0943347566.SGD","LU0795875169.SGD","SG9999014914.USD","LU0784385170.HKD","LU0158827948.USD","LU0080751232.USD","IE0004086264.USD","LU1242518857.USD","LU1548497426.USD","LU0320765992.SGD","SG9999002224.SGD","FUTY","IE00BYXW3230.USD","LU2211815571.USD","LU0149725797.USD","LU2133065610.SGD","IE000KEQY171.SGD","LU0738911758.USD","LU0889565833.HKD","LU1861214812.USD","LU1035773651.USD","CMAG","LU1323610961.USD","LU1868836757.USD","IE00BMPRXQ63.HKD","LU2242650005.HKD","IE00B5949003.HKD","PANG","IE00B3SWFQ91.USD","LU2168564495.EUR","LU0354030511.USD","IE00B19Z9505.USD","LU0964807845.USD","LU1037948897.HKD","LU2506952170.USD","LU0070302665.USD","LU2360032135.SGD","LU1868837136.USD","LU1989764664.SGD","BK4553","LU1861215975.USD","SG9999014906.USD","LU1144417596.USD","IE0034235295.USD","LU0545039389.USD","LU2125154935.USD","LU1934455863.HKD","LU1066051498.USD","LU2191332357.HKD","SG9999018865.SGD","LU2272731600.USD","LU0912757837.SGD","IE0001KFT4U8.USD","LU0316494557.USD","LU0557290698.USD","BK4592","LU0642271901.SGD","LU2468319806.SGD","LU1989772923.USD","BK4097","LU2237443622.USD","LU0985320562.USD","SG9999014880.SGD","LU0354030438.USD","LU2168563687.JPY","LU2417539215.USD","BK4170","LU0345768153.USD","LU0882574055.USD","XAR","BUG","LU0081259029.USD","LU1868837300.USD","LU2125909247.SGD","LU0528227936.USD","IE00BZ1G4Q59.USD","LU1242518931.SGD","IE00BMPRXR70.SGD","BK4023","LU2065169927.USD","LU0061475181.USD","LU0203201768.USD","APLY","LU0211327993.USD","ALAB","FSTA","BK4550","LU2362541273.HKD","CDNG","LU1585245621.USD","LU1066051811.HKD","LU0289739699.SGD","BK4139","IE0003U64NQ7.SGD","LU0950375773.USD","LU1815333072.USD","LU1868836914.USD","LU2420271590.USD","LU2456880835.USD","FTEC","LU0353189763.USD","LU2360107168.USD","LU2463028550.USD","IE00BD4GTT62.SGD","LU0786609619.USD","PSWD","LU1267930730.SGD","LU0094547139.USD","LU0689472784.USD","IE00BN8TJ469.HKD","BK4576","LU0820561818.USD","IE00BD4GTW91.USD","BK4527","LU0289739343.SGD","LU2272731782.SGD","IE00BFSS8Q28.SGD","LU2355687059.USD","SAAPLmain","LU0109392836.USD","BK4560","SPAM","IE00BQXX3D17.EUR","LU1951198990.SGD","LU0942090050.USD","LU2362540622.SGD","TYLG","LU0323239441.USD","LU0784385840.USD","LU2065170008.USD","LU2999663052.SGD","LU0057025933.USD","IBB","LU2095319765.USD","VT","LU1244550494.USD","LU1935043536.SGD","LU1145028129.USD","IE00BJTD4V19.USD","LU2552382058.USD","LU2384288077.EUR","LU0154236417.USD","IE00B19Z9Z06.USD","IE00BLSP4452.SGD","RTH","LU2108987350.USD","LU0069063385.USD","LU1978683503.SGD","SG9999015986.USD","LU2750360997.AUD","IE00BN0W2T93.GBP","LU1992135472.HKD","IE00BBT3K403.USD","IE00BJLML261.HKD","SG9999000418.SGD","IE00BJJMRX11.SGD","LU0056508442.USD","HK0000320223.HKD","IE00BJJMRY28.SGD","LU2430703251.USD","SMHX","IE0034235188.USD","AAPD","LU1732800096.USD","GUNZ","LU1712237335.SGD","BK4571","SG9999014567.USD","LU0345770308.USD","LU2462591350.SGD","LU0476273544.USD","LU0109394709.USD","LU2237438978.USD","LU2023250330.USD","LU2764263039.SGD","LU0784384876.USD","METV","BK4573","JXI","LU0979878070.USD","LU1496350502.SGD","AAPW","LU2471134796.USD","JGRO","IE00BD4GTV84.USD","LU2089984988.USD","LU2362541513.USD","WCLD","LU0310800379.SGD","LU0097036916.USD","LU1400636574.HKD","LU1935042488.USD","BK4515","LU0553294199.USD","BK4141","IE000MB6IJN5.SGD","LU0444971666.USD","BK4574","LU1674673691.USD","IE00B775H168.HKD","LU0784383803.USD","IE00BD6J9T35.USD","BK4566","LU0210528500.USD","LU2506952337.HKD","IE00BDCRKT87.USD","LU0096362180.USD","LU2125154778.USD","LU2462591277.SGD","LU2168564149.EUR","LU2764263203.CNY","LU1267930490.SGD","LU1235294995.USD","WCBR","LU3102509885.SGD","LU2361044949.HKD","LU0175139822.USD","LU1732799900.SGD","LU0472753341.HKD","IE0005OL40V9.USD","LU2506952097.USD","BK4585","IE00B19Z3581.USD","LU1169589451.USD","LU2125909759.SGD","LU0256863902.USD","LU0323240290.USD","LU0211328371.USD","LU0058720904.USD","LU2063271972.USD","CDNS","LU1400636657.SGD","IE00BQXX3C00.GBP","LU0320765489.SGD","CEGX","LU2111349929.HKD","LU1914381329.SGD","LU2764262908.HKD","LU2458330243.SGD","LU0077335932.USD","LU0889565916.HKD","BK4598","LU0683600562.USD","LU1093756325.SGD","AIFD","BK4528","LU0029864427.USD","LU2106854487.HKD","IE0034235303.USD","LU0345770993.USD","LU0823417737.USD","LU0949170426.SGD","BK4567","BK4596","LU1506573853.SGD","LU2505996509.AUD","BK4081","LU0345769631.USD","LU0289961442.SGD","XLP","LU1621768115.EUR","LU0143551892.USD","IE000W1ABFV2.USD","LU1496350171.SGD","LU1803068979.SGD","ALA","IE0004445239.USD","LU2360106780.USD","VPU","LU1169590202.USD","LU2506952410.USD","LU2264538146.SGD","LU0072462426.USD","LU1989771016.USD","LU0174119429.USD","IOSX","IE00BN0W2W23.USD","LU1582987324.SGD","IE00B4JS1V06.HKD","LU0198837287.USD","LU2077746001.SGD","SPRX","SG9999014559.SGD","LU0728928796.USD","LU1551013425.SGD","LU1934455194.USD","PALU","IXN","SG9999018857.SGD","LU2506951958.HKD","IE00B3S45H60.SGD","LU1571399168.USD","LU2931357623.SGD","LU0708994859.HKD","IE00BK4W5L77.USD","LU1815336760.USD","IE00BLSP4239.USD","LU0203202063.USD","LU1066051225.USD","LU2471134879.HKD","LU2506951875.HKD","IE000SO60NU8.SGD","LU2271345857.HKD","LU1003077747.HKD","IE00BKVL7J92.USD","LU1301847155.USD","SPTE","LU0823421416.USD","LU0726765562.USD","IE00BN0W2V16.EUR","LU1430594728.SGD","LU2347655156.SGD","LU0957791311.USD","IE000F7OJYX1.SGD","LU0124676726.USD","LU0267386448.USD","LU1069347547.HKD","IE00BZ9MQY76.HKD","IHAK","HK0000320264.USD","IE0000B7K699.USD","LU0417517546.SGD","AXUP","IE00BWXC8680.SGD","LU1923622291.USD","LU0788109477.HKD","LU1935042991.SGD","LU1718418525.SGD","LU0323591593.USD","LU2552382132.HKD","BK4597","LU2461242641.AUD","LU0345768740.USD","LU0494093205.USD","LU2381873111.SGD","LU2092937148.SGD","LU0823434583.USD","LU2360107325.USD","LU2097829019.USD","LU2065171311.SGD","IGV","IE000WAW04H5.SGD","LU0310799852.SGD","LU0820562030.AUD","IE00B775SV38.USD","LU2403377893.USD","LU0048584097.USD","LU0724617625.USD","IE00B1BXHZ80.USD","BK4505","LU0107464264.USD","LU2347655073.USD","LU1934455277.USD","LU2750360641.GBP","LU0082616367.USD","CNAV","LU1691799644.USD","LU2247934214.USD","IE0009356076.USD","LU2089283258.USD","BK4554","LU0868494708.USD","LU1670756490.USD","LU1699723380.USD","BK4559","LU0312595415.SGD","LU1935042215.USD","BK4579","LU2896262040.SGD","IE00B4YYXB79.USD","LU1804176565.USD","CHAT","IE0004445015.USD","REGN","BK4512","LU2242649171.HKD","LU1721428347.USD","LU2756315664.SGD","IE00B19Z9P08.USD","SOXY","BK4588","LU1116320737.USD","LU1244550221.USD","LU1291159041.SGD","LU1202635105.USD","LU2237443895.HKD","BK4532","LU0320765059.SGD","LU0256863811.USD","LU1621767810.EUR","LU2361045086.USD","LU1989772840.SGD","BBH","UTES","LU0133085943.USD","LU1988902786.USD","LU0251132253.USD","LU2462157665.USD","LU0861579265.USD","LU0965509010.AUD","LU1979441026.SGD","TBXU","LU0957808578.USD","LU1989763005.USD","LU2290526834.HKD","LU1839511570.USD","IE00BN29S564.USD","LU0640476718.USD","LU2517655028.SGD","LU2125909916.SGD","SG9999002232.USD","IE00BQXX3F31.USD","LU0787776722.HKD","IE00BMPRXN33.USD","LU2250418816.HKD","LU2487616109.SGD","LU1621767737.EUR","CRWL","IE00BDRTCR15.USD","LU1989764748.USD","LU0823417653.USD","LU2168564222.USD","BK4534","SG9999015945.SGD","SG9999001424.SGD","SGXZ31699556.SGD","LU1069344957.HKD","LU1861220033.SGD","UPW","LU1035775433.USD","WDAY","CRWC","LU1046421795.USD","LU0823421333.USD","LU1119994496.HKD","LU1084165304.USD","TRUU","GB00BDT5M118.USD","LU1232071149.USD","LU1400636491.USD","LU2517655291.USD","LU0882574139.USD","LU2298322129.HKD","LU0070217475.USD","LU2083900584.USD","LU2028103732.USD","WMT","LU0210536198.USD","LU0238689110.USD","SG9999015978.USD","LU2517655374.HKD","LU0011850046.USD","AXON","PANW","BK4501","BK4606","LU2092627202.USD","BK4575","LU0965509283.SGD","LU0444973449.USD","LU2097344431.USD","LU0265550359.USD","LU1645745479.HKD","LU2477742899.HKD","BK4613","LU1074936037.SGD","LU0302445910.USD","EYES","LU2275660780.HKD","LU2746668974.SGD","LU1974910355.USD","TTXU","LU1629891620.HKD","LU1621768206.USD","LU0215105999.USD","LU2236285917.USD","ABFL","LU0128525929.USD","LU0210533765.USD","LU0820561909.HKD","LU1366192091.USD","VGT","LU2471134952.CNY","LU0689626769.HKD","LU0965508806.USD","LU1261432733.SGD","LU2746668461.USD","XLK","LU0170899867.USD","LU0127658192.USD","IE00B19Z8W00.USD","SG9999014898.SGD","LU2458330169.SGD","LU2860962120.EUR","LU1720051108.HKD","SG9999015341.SGD","ROM","SG9999017495.SGD","LU1917777945.USD","BK4187","LU2505996681.GBP","LU1923623000.USD","LU1989773731.SGD","LU0266013472.USD","LU1037948541.HKD","AAPL","IE0002270589.USD","IE000YTNTUN2.SGD","IE00B19Z3B42.SGD","AAPU","LU0314104364.USD","AAPY","LU2087621335.USD","LU2430703095.HKD","LU1551013342.USD","TRUO","LU1093756168.USD","LU2023250504.SGD","IE00B1XK9C88.USD","LU2357305700.SGD","LU2954938101.SGD","LU0724618433.USD","LU2125909593.SGD","IE00BK4W5M84.HKD","LU0079474960.USD","LU0053666078.USD","LU1642822529.SGD","XSD","LU1791710582.SGD","LU1935043023.USD","BK4507","LU0158827781.USD","LU1316542783.SGD","LU0868494617.USD","LU2047632596.USD","LU1951200564.SGD","LU0661504455.SGD","AAPE","LU0345769128.USD","BK4581","LU0511384066.AUD","LU1582987597.SGD","AIPI","LU2087625088.SGD","LU2361044865.SGD","LU0348723411.USD","IE00BFSS7M15.SGD","LU0708995401.HKD","LU2265009873.SGD","LU2168564065.EUR","LU2213496289.HKD","LU1206713676.USD","LU0234572021.USD","BK4155","LU1116320901.HKD","LU1244550577.SGD","LU0466842654.USD","LU1868836591.USD","LU1582986433.USD","LABX","LU0823434740.USD","LU2089284900.SGD","IE00BKDWB100.SGD","LU0965509101.SGD","LU1923622614.USD","LU2089985449.USD","SG9999014542.SGD","LU0162691827.USD","LU2452424414.USD","LU1852331112.SGD","LU1861219969.SGD","LU2237443978.SGD","LU0289960550.SGD","LU1066053197.SGD","LU2433249047.HKD","IE000ITXATA3.USD","LU2100268510.USD","LU2237443382.USD","HK0000306701.USD","LU2237443465.HKD","IE00BSNM7G36.USD","IE00BJTD4N35.SGD","LU2720916845.USD","LU1992135399.USD","LU1064131342.USD","MACW.SI","HK0000819398.USD","LU0114720955.EUR","CIBR","LU1582986359.USD","XLU","COWG","LU0208291251.USD","BK4551","LU1674673428.USD","LU1823568750.SGD","LU0072461881.USD","LU2210149790.SGD","LU1267930573.SGD","LU2097344357.USD","LU0949170772.SGD","LU1720051017.SGD","LU2286300806.USD","BK4548","LU2471134523.USD","HAKY","LU0061474960.USD","LU0795875086.SGD","HK0000914660.USD","BK4543","LU2023250843.SGD","LU1366333091.USD","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664854756","title":"Vertex Pharmaceuticals Closes Crinetics Pharmaceuticals Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2664854756","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664854756?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:51","pubTimestamp":1788270662,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals  has completed its acquisition of Crinetics Pharmaceuticals , Vertex said on Tuesday.Following the acquisition's closing, Jonathan Poole will take over Vertex's chief financial officer role, effective Jan. 1, Vertex said. Poole currently serves as Vertex's senior vice president for finance, the company said.Charles Wagner, chief operating and financial officer of Vertex, will expand his COO role to head Crinetics' integration, effective immediately, Vertex said.Price: 549.07, Change: +4.55, Percent Change: +0.83","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","IE0002270589.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","LU1069344957.HKD","LU1674673691.USD","LU2236285917.USD","BK4139","GNMX","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD","TBXU","VRTX","LU1559883803.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4567","PBE","CRNX","LU0432979614.USD","BIB","IE00B19Z3581.USD","LU0320765992.SGD","IE00B894F039.SGD","VERX","LU0289739699.SGD","LU0757428866.USD","LU1430594728.SGD","LU0079474960.USD","LU0823416689.USD","IE00BFTCPJ56.SGD","BK4533","LU0058720904.USD","LU0566484027.USD","IBB","IBBQ","LU1778281490.HKD","IDNA","LU2089984988.USD","LU0234570918.USD","LU2468319806.SGD","BBH","LU2362541273.HKD","LU2456880835.USD","LU1093756325.SGD","LU0889565916.HKD","LU0417517546.SGD","IE0009355771.USD","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664144854","title":"Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2664144854","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664144854?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:25","pubTimestamp":1788269142,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals (VRTX) announced the successful completion of the acquisition of Crinetics Pharmaceuticals (CRNX). Vertex also announced the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vertex-pharmaceuticals-completes-acquisition-of-crinetics-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0234570918.USD","LU2362541513.USD","PBE","LU0079474960.USD","IE00B19Z9P08.USD","VERX","LU1093756325.SGD","CRNX","LU0889565916.HKD","IDNA","LU0432979614.USD","SGXZ57979304.SGD","SG9999013999.USD","LU1093756168.USD","LU1674673428.USD","LU2468319806.SGD","IE00B2B36J28.USD","SG9999001176.USD","IE00BJT1NW94.SGD","BK4007","LU0109394709.USD","IBBQ","BIB","LU0058720904.USD","BBH","IE0002141913.USD","IE00B4R5TH58.HKD","LU2236285917.USD","LU2462157665.USD","VRTX","LU0823416689.USD","LU2237438978.USD","IE00B894F039.SGD","LU1430594728.SGD","BK4567","LU0320765992.SGD","LU1035775433.USD","LU0757428866.USD","LU0256863811.USD","IBB","LU2089984988.USD","LU0061475181.USD","BK4023","LU0417517546.SGD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","IE00BZ9MQY76.HKD","TBXU","LU1815336091.USD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664851485","title":"Vertex Names Jonathan Poole CFO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664851485","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664851485?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:04","pubTimestamp":1788267895,"startTime":"0","endTime":"0","summary":"Vertex names Jonathan Poole CFO effective Jan. 1, 2027Vertex expanded its executive leadership team following the close of its Crinetics acquisition on Sept. 1, 2026.Charles Wagner, EVP and chief oper","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL4Tv8z0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","EVLO","LU0289739699.SGD","IE0009355771.USD","BK4599","GNCAQ","BK4532","IBB","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00B19Z3B42.SGD","PJP","SGXZ57979304.SGD","LU2468319806.SGD","LU2089984988.USD","SG9999013999.USD","AMGN","VRTX","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","BK4139","BBH","IBBQ","IE00B2B36J28.USD","LU1585245621.USD","LU1093756325.SGD","IE00B19Z9P08.USD","TBXU","BK4581","LU1093756168.USD","LU2362540622.SGD","LU0234570918.USD","LU0061475181.USD","LU2362541273.HKD","LU0079474960.USD","LU0823416689.USD","GNMX","LU1023059063.AUD","LU0432979614.USD","BK4588","SG9999001176.USD","LU0109394709.USD","BK4567","LU1778281490.HKD","BIB","LU1035775433.USD","BK4566","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664117851","title":"Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership Team","url":"https://stock-news.laohu8.com/highlight/detail?id=2664117851","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664117851?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:03","pubTimestamp":1788267780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA44TDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","IE00B19Z9P08.USD","IE0002270589.USD","LU0320765992.SGD","BIB","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU2236285917.USD","SG9999001176.SGD","GNMX","BK4585","IBBQ","BK4567","BK4139","LU1674673691.USD","SGXZ57979304.SGD","IE00B2B36J28.USD","IDNA","BK4588","LU1674673428.USD","IE0002141913.USD","IE00BZ9MQY76.HKD","TBXU","LU0823416689.USD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU1430594728.SGD","IE00B19Z9Z06.USD","VRTX","LU2417539215.USD","LU2468319806.SGD","LU0079474960.USD","LU1778281490.HKD","LU0234570918.USD","LU0432979614.USD","BK4532","LU1035775433.USD","LU2362541513.USD","BBH","LU1093756168.USD","LU2456880835.USD","IE0009355771.USD","LU1585245621.USD","IE00B19Z3581.USD","LU2237438978.USD","LU2324357040.USD","PBE","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664856297","title":"Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664856297","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664856297?lang=en_us&edition=fundamental","pubTime":"2026-09-01 20:00","pubTimestamp":1788264000,"startTime":"0","endTime":"0","summary":"BRIDGEWATER N.J., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced that Alan Bash, interim Chief Executi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3354079/0/en/legend-biotech-to-participate-in-the-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNCR","FBT","MEMS","XBI","XLV","BK4139","TBXU","LU0128526141.USD","BK4585","LEGN","MEDI","HCSG","BK4505","LFSC","BK4581","CANC","SYNB","BK4588","IBB","LABU","BK4137","IBBQ","GNOM","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}